Introduction Cell-based high throughput screening (HTS) platforms have significantly accelerated drug discovery by providing high-content, scalable, and clinically relevant data early in the screening pipeline. Cell-based assays have become indispensable tools in HTS, enabling researchers to rapidly evaluate thousands to millions of molecules for biological activity. In the context of high throughput screening of molecules […]
Introduction Cell-based high throughput screening (HTS) platforms have significantly accelerated drug discovery by providing high-content, scalable, and clinically relevant data early in the screening pipeline. Cell-based assays have become indispensable
The landscape of cancer immunotherapy is rapidly evolving with the emergence of several cutting-edge modalities. Some examples include genetically engineered chimeric antigen receptor (CAR) immune cell subsets, neoantigen vaccines
Press Release | Marin Biologic Labs Achieves Flawless FDA Inspection for Second Consecutive Year, Expands Biopharmaceutical Services What are PROTACs? Proteolysis Targeting Chimeric (PROTAC) drugs are innovative molecules that utilize
Antibody Drug Conjugate (ADC) Drugs Kill Target Cells What is an Antibody Drug Conjugate (ADC)? What potency assays are needed for an ADC? How can Marin Biologic Laboratories help you
CANCER HIGHLIGHT | Potency Assay for Bispecific Antibody Constructs Blog Highlights: What is a bispecific antibody? How is a potency assay for a bispecific antibody for cancer immunotherapy performed? How can MarinBio
Introducing Our Cutting-Edge ELISA Method Bispecific antibodies are a groundbreaking class of molecules that have revolutionized targeted therapies. These unique antibodies are designed to simultaneously bind two different targets. Some
Immunogene therapy is a combination of two different treatment methods: gene therapy and immunotherapy. In immunogene therapy, a protein/antibody, gene, or nucleic acid molecule is delivered to patients by gene
Immunogenicity assays are designed to determine the immune response to biotherapeutics such as protein, peptide, antibody, oligonucleotide or DNA/RNA-based drugs and its clinical impact. In a recent IQ Consortium industry
Why have Lot Release Potency Testing? The US FDA requires that manufactured drug lots pass critical analysis before release by the manufacturer for clinical use. These include potency, sterility, purity
Why Do STABILITY Studies / Testing? Stability studies are performed to ensure that pharmaceutical products will be at the acceptable level of quality throughout the period that they are available
